trial · primary record
Pacritinib
Myelofibrosis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 26 |
| Primary completion | 2030-05-24 |
| Primary endpoint | Change in spleen volume |
| Registry ID | NCT07447817 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:46.367Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07447817
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.